Spire's coated dialysis catheter:
This article was originally published in Clinica
Spire Biomedical has received US FDA 510(k) clearance to sell a long-term haemodialysis catheter, called Decathlon, which is treated with a coating designed to address device-related complications typically associated with dialysis treatment. The coating is firmly bonded to both internal and external catheter surfaces and has been shown to reduce thrombus and fibrin sheath formation in both in vitro and animal studies, said the Bedford, Massachusetts firm.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.